Everyday people photos equip AI for skin-cancer screening

AI can be taught to flag possible skin cancers on photos taken with smartphone cameras—and the images can be ordinary “people shots” rather than closeups of suspicious lesions.

The concept passed its audition at MIT, where biomedical engineers trained, tested and validated deep convolutional networks with more than 38,000 images.

Along with dermatology-grade images, the dataset included more than 15,000 wide-field shots captured with consumer cameras.

Using lesion classification by experienced dermatologists as the ground truth, the researchers found their system achieved sensitivity and specificity of right around 90% each when tasked with separating suspicious lesions from benign skin discolorations and busy backgrounds.

In clinical use, the authors note, such automated screening prowess could help patients head to the dermatologist for early diagnosis—or at least avoid burdensome individual lesion imaging.

“Rather than evaluate a single lesion at a time looking for predetermined signs of neoplasia, the algorithm identifies lesions that differ from most of the other marks on that patient’s skin, flagging them for further examination and ranking them in order of suspiciousness,” the authors explain in their study summary. “The algorithm performed similarly to board-certified dermatologists and could potentially be used at primary care visits to help clinicians triage suspicious lesions for follow-up.”

Science Translational Medicine published the study Feb. 17. Lead and senior authors are, respectively, Luis Soenksen, PhD, and Martha Gray, PhD.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”